Skip to main content

Silvia Cabrera Diaz

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Silvia Cabrera Diaz

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

NUEVAS APROXIMACIONES PARA EL DIAGNÓSTICO DE CÁNCER DE ENDOMETRIO.

IP: Gil Moreno, Antonio
Collaborators: Cabrera Diaz, Silvia, Rebull Santamaria, Marta, NUEVAS APROXIMACIONES PARA EL DIAGNÓSTICO DE CÁNCER DE ENDOMETRIO., De la Calle Fuentes, Irene
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 369335
Reference: CPP2021-008440
Duration: 14/02/2022 - 13/02/2025

Ministerio de Ciencia

Recerca biomèdica en ginecologia

IP: Gil Moreno, Antonio
Collaborators: Rodriguez Gómez - Hidalgo , Natalia, Suarez Salvador, Elena, Poza Barrasus, Jose Luis, Bebia Conesa, Vicente , García Jiménez, Angel, Perez Benavente, Maria Asuncion, Masferrer Ferragutcasas, Carina, Colas Ortega, Eva, Salicrú Riera, Sabina, De la Torre Fdez de Vega, Fco Javier, Recerca biomèdica en ginecologia, Cubo Abert, Montserrat, Cabrera Diaz, Silvia, Mañalich Barrachina, Laura, Rebull Santamaria, Marta, Armengol Alsina, Mireia, Recerca biomèdica en ginecologia, De la Calle Fuentes, Irene, Sánchez Iglesias, José Luis, Bradbury Lobato, Melissa, Villafranca Magdalena, Beatriz, Denizli , Melek, Cabre Fernandez, Paula
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 40000
Reference: 2021 SGR 01157
Duration: 01/01/2022 - 31/12/2024

Cytomark - Desarrollo de un test diagnóstico personalizado y no invasivo de cáncer de endometrio en el fluido cervical

IP: Colas Ortega, Eva
Collaborators: García Jiménez, Angel, Cabrera Diaz, Silvia, Gil Moreno, Antonio, Denizli , Melek
Funding agency: Instituto de Salud Carlos III
Funding: 110715
Reference: AC21_2/00030
Duration: 01/01/2022 - 31/12/2024

ADVANCING ON THE DEVELOPMENT OF A NON-INVASIVE TOOL TO EARLY DIAGNOSE ENDOMETRIAL CANCER

IP: Colas Ortega, Eva
Collaborators: Masferrer Ferragutcasas, Carina, De la Torre Fdez de Vega, Fco Javier, Cabrera Diaz, Silvia, De la Calle Fuentes, Irene, Villafranca Magdalena, Beatriz
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI20/00644
Duration: 01/01/2021 - 31/12/2024

Related news

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

The product is now in the last stage of prototyping and will move to the verification and validation stages thanks to current fundraising.

Related professionals

David Berlana Martín

David Berlana Martín

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Mª Carmen López  Arribas

Mª Carmen López Arribas

Research technician
Molecular Medical Imaging
Read more
Victoria Valls Comamala

Victoria Valls Comamala

Administration and Management
Read more
Jorge Serra Pueyo

Jorge Serra Pueyo

Main researcher
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.